Skip to main content
OpenTrials

Clinical trial condition

Meningococcal Infections

Explore clinical trials studying Meningococcal Infections. Study availability and eligibility vary by location and protocol.

216 public trials 4 recruiting studies
Refine in advanced search Browse all conditions

Meningococcal Infections trial results

Completed

Trial to Assess Immunogenicity and Safety of GlaxoSmithKline (GSK) Biologicals' Meningococcal ABCWY Vaccine as Compared to Meningococcal B Vaccine in Adolescents

NCT02212457

Conditions
Bacterial Infections, Bacterial Infections and Mycoses, Gram-Negative Bacterial Infections, +4 more
Locations
  • GSK Investigational Site Jonesboro, Arkansas, United States
  • GSK Investigational Site Hialeah, Florida, United States
  • GSK Investigational Site Melbourne, Florida, United States
  • GSK Investigational Site Augusta, Kansas, United States
View all 32 locations
View Trial Details
Completed

Evaluation of Antibody Persistence Following 4 MenACWY Vaccinations

NCT02446691

Conditions
Bacterial Infections, Bacterial Infections and Mycoses, Gram-Negative Bacterial Infections, +4 more
Locations
  • GSK Investigational Site Ansan-si, South Korea
  • GSK Investigational Site Incheon, South Korea
  • GSK Investigational Site Jeonju, South Korea
  • GSK Investigational Site Seongnam-si, South Korea
View Trial Details
Completed

The Long-term Antibody Persistence of GSK Biologicals' Meningococcal Vaccine GSK134612 in Healthy Toddlers

NCT00718666

Conditions
Bacterial Infections, Bacterial Infections and Mycoses, Central Nervous System Bacterial Infections, +12 more
Locations
  • GSK Investigational Site Benton, Arkansas, United States
  • GSK Investigational Site Little Rock, Arkansas, United States
  • GSK Investigational Site Antioch, California, United States
  • GSK Investigational Site Fremont, California, United States
View all 14 locations
View Trial Details
Completed

Immunogenicity and Safety of Meningococcal Vaccine GSK134612 Given as 1 or 2 Doses to Healthy 9-12 Months Old Toddlers.

NCT00471081

Conditions
Bacterial Infections, Bacterial Infections and Mycoses, Gram-Negative Bacterial Infections, +4 more
Locations
  • GSK Investigational Site Birmingham, Alabama, United States
  • GSK Investigational Site Benton, Arkansas, United States
  • GSK Investigational Site Little Rock, Arkansas, United States
  • GSK Investigational Site Antioch, California, United States
View all 19 locations
View Trial Details
Completed

Persistence of Antibodies After Meningococcal Vaccine PF-06866681 in Healthy Children

NCT01900899

Conditions
Bacterial Infections, Bacterial Infections and Mycoses, Gram-Negative Bacterial Infections, +4 more
Locations
  • Espoo Vaccine Research Clinic Espoo, Finland
  • Tampereen yliopisto/ Etela-Helsingin rokotetutkimusklinikka Helsinki, Finland
  • Helsinki East Vaccine Research Clinic Helsinki, Finland
  • Tampereen Yliopisto/ Jarvenpaan rokotetutkimusklinikka Jarvenpaa, Finland
View Trial Details

Related conditions